Last reviewed · How we verify
NCT04518150
Combined Bilateral Uterine Artery Ligation and Bakri Balloon During Cesarean Section
NA trial testing Bakri balloon in Placenta Previa in 150 participants. Status unknown.
31 August 2022
Quick facts
| Lead sponsor | Aswan University Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 150 |
| Start date | 1 September 2020 |
| Primary completion | 31 August 2022 |
| Estimated completion | 31 October 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Bakri balloon
- Bilateral Uterine Artery Ligation
Conditions studied
- Placenta Previa — all drugs for Placenta Previa →
Sponsor
Aswan University Hospital
Who can join
Adults 18 to 45, female only, with Placenta Previa. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will be performed to compare the effectiveness of routine Bakri balloon tamponade and Bilateral Uterine Artery Ligation during cesarean section in patients with placenta previa
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04518150
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bakri balloon
Trials testing the same drug.
- NCT01980173 — Medico-economic Comparison of Postpartum Hemorrhage Management Using the Bakri Balloon and Standard Care · NA · terminated
Other recruiting trials for Placenta Previa
Currently open trials in the same condition.
- NCT07025954 — Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta · NA · recruiting
- NCT06849349 — EXAMINATION OF SOME MOLECULES IN PLACENTAS OF PATIENTS WITH PLACENTA PREVIA, PLACENTA PERCREATA · recruiting
- NCT06867874 — Syncytiotrophoblast-derived Extracellular Vesicles in Placenta Previa and Accreta Spectrum · NA · recruiting
Other Aswan University Hospital trials
Trials by the same sponsor.
- NCT06491394 — Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats · Phase 4 · completed
- NCT06211088 — Famotidine Versus Placebo in Emergency Pediatric Surgery As a Risk to Postoperative Nausea and Vomiting · NA · completed
- NCT06583590 — Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction · Phase 2, PHASE3 · recruiting
- NCT06537323 — Femoral Nerve Block, Periarticular Nerve Group (PENG) Block, and Preoperative IV Fentanyl · NA · recruiting
- NCT06535256 — Compare Intraperitoneal Instillation of Bupivacaine+dexmedetomidine Versus Bupivacaine+dexamethasone on Postoperative Pa · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04518150 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aswan University Hospital
- Last refreshed: 21 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04518150.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing